Indoco Remedies Limited (INDOCO) - Total Assets

Latest as of March 2026: Rs25.93 Billion INR ≈ $280.45 Million USD

Based on the latest financial reports, Indoco Remedies Limited (INDOCO) holds total assets worth Rs25.93 Billion INR (≈ $280.45 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore INDOCO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Indoco Remedies Limited - Total Assets Trend (2004–2026)

This chart illustrates how Indoco Remedies Limited's total assets have evolved over time, based on quarterly financial data. Check Indoco Remedies Limited (INDOCO) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Indoco Remedies Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Indoco Remedies Limited's total assets of Rs25.93 Billion consist of 46.0% current assets and 54.0% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	1.3%
Accounts Receivable	Rs4.94 Billion	19.0%
Inventory	Rs4.05 Billion	15.6%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs1.79 Billion	6.9%
Goodwill	Rs215.20 Million	0.8%

Asset Composition Trend (2004–2026)

This chart illustrates how Indoco Remedies Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Indoco Remedies Limited.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Indoco Remedies Limited's current assets represent 46.0% of total assets in 2026, a decrease from 67.1% in 2004.
Cash Position: Cash and equivalents constituted 1.3% of total assets in 2026, down from 4.2% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2004.
Asset Diversification: The largest asset category is accounts receivable at 19.0% of total assets.

Indoco Remedies Limited Competitors by Total Assets

Key competitors of Indoco Remedies Limited based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Jiangsu Hengrui Medicine Co Ltd SHG:600276	China	CN¥68.33 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Ajanta Pharma Limited NSE:AJANTPHARM	India	Rs56.72 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	China	CN¥5.95 Billion

Indoco Remedies Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.13	1.24	1.53
Quick Ratio	0.75	0.72	0.95
Cash Ratio	0.00	0.02	0.00
Working Capital	Rs1.41 Billion	Rs1.93 Billion	Rs2.16 Billion

Indoco Remedies Limited - Advanced Valuation Insights

This section examines the relationship between Indoco Remedies Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.36
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	6.7%
Total Assets	Rs25.93 Billion
Market Capitalization	$203.35 Million USD

Valuation Analysis

Below Book Valuation: The market values Indoco Remedies Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Indoco Remedies Limited's assets grew by 6.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Indoco Remedies Limited (2004–2026)

The table below shows the annual total assets of Indoco Remedies Limited from 2004 to 2026.

Year	Total Assets	Change
2026-03-31	Rs25.93 Billion ≈ $280.45 Million	+6.72%
2025-03-31	Rs24.30 Billion ≈ $262.79 Million	+13.30%
2024-03-31	Rs21.45 Billion ≈ $231.94 Million	+29.34%
2023-03-31	Rs16.58 Billion ≈ $179.33 Million	+11.58%
2022-03-31	Rs14.86 Billion ≈ $160.72 Million	+13.01%
2021-03-31	Rs13.15 Billion ≈ $142.22 Million	+3.42%
2020-03-31	Rs12.72 Billion ≈ $137.52 Million	+1.08%
2019-03-31	Rs12.58 Billion ≈ $136.05 Million	+1.76%
2018-03-31	Rs12.36 Billion ≈ $133.70 Million	+3.28%
2017-03-31	Rs11.97 Billion ≈ $129.45 Million	+24.20%
2016-03-31	Rs9.64 Billion ≈ $104.23 Million	+13.97%
2015-03-31	Rs8.46 Billion ≈ $91.45 Million	+15.93%
2014-03-31	Rs7.29 Billion ≈ $78.88 Million	+5.81%
2013-03-31	Rs6.89 Billion ≈ $74.55 Million	+5.02%
2012-03-31	Rs6.56 Billion ≈ $70.98 Million	+16.26%
2011-03-31	Rs5.65 Billion ≈ $61.06 Million	+17.85%
2010-03-31	Rs4.79 Billion ≈ $51.81 Million	+15.24%
2009-03-31	Rs4.16 Billion ≈ $44.96 Million	+11.00%
2008-03-31	Rs3.75 Billion ≈ $40.50 Million	+7.93%
2007-03-31	Rs3.47 Billion ≈ $37.53 Million	+11.69%
2006-03-31	Rs3.11 Billion ≈ $33.60 Million	+9.05%
2005-03-31	Rs2.85 Billion ≈ $30.81 Million	+89.27%
2004-03-31	Rs1.51 Billion ≈ $16.28 Million	--

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic

Market Cap

$203.35 Million

Rs18.80 Billion INR

Market Cap Rank

#16592 Global

#854 in India

Share Price

Rs204.00

Change (1 day)

+5.63%

52-Week Range

Rs164.00 - Rs339.10

All Time High

Rs511.66